Search Result

Results for "

MAGE-A4

" in MedChemExpress (MCE) Product Catalog:

By Targets:	E1/E2/E3 Enzyme (1) Small Interfering RNA (siRNA) (3)
By Research Areas:	Cancer (4) Inflammation/Immunology (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Oligonucleotides

MAGEA4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MAGEA4 Human Pre-designed siRNA Set A contains three designed siRNAs for MAGEA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Magea4 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Magea4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Magea4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

JWP24	E1/E2/E3 Enzyme	Cancer
JWP24 is the first cell membrane-permeable peptide inhibitor of *MAGE-A4, with an IC₅₀* of 200 nM against human MAGE-A4. JWP24 binds to intracellular targets while retaining binding activity, disrupts the interaction between MAGE-A4 and RAD18, and does not induce cytotoxicity at effective concentrations. JWP24 is applicable for cancer-related research .

Magea4 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Magea4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Magea4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.	Product Name	Target	Research Area

HY-P11129

MAGE-A4 (286-294)	Peptides	Cancer
MAGE-A4 (286-294) is a polypeptide derived from the 286th to 294th amino acids of the MAGE-A4 protein. MAGE-A4 (286-294) binds HLA-A02 with an affinity of 560.08 nM and an IC₅₀* of 8.52 nM. MAGE-A4 (286-294) can be detected in various types of cancers (such as esophageal cancer, lung squamous cell carcinoma, bladder cancer). MAGE-A4 (286-294) can be used to produce CAR-T cells and to develop CAR-T cell therapy .

HY-P10491

MAGE A4 (230-239)	Peptides	Cancer
MAGE A4 (230-239) is a peptide sequence derived from the MAGE-A4 protein. MAGE A4 (230-239) is an immunogenic epitope that can activate T cells and trigger the killing of tumor cells expressing MAGE-A4. MAGE A4 (230-239) is used in the development of next-generation T cell-based immunotherapies .

HY-P11621

JWP24	E1/E2/E3 Enzyme	Cancer
JWP24 is the first cell membrane-permeable peptide inhibitor of *MAGE-A4, with an IC₅₀* of 200 nM against human MAGE-A4. JWP24 binds to intracellular targets while retaining binding activity, disrupts the interaction between MAGE-A4 and RAD18, and does not induce cytotoxicity at effective concentrations. JWP24 is applicable for cancer-related research .

HY-P10676

cMCF02A	Peptides	Cancer
cMCF02A is a potent inhibitory peptide of the *MAGE-A4* binding axis and can be used in melanoma-related research .

Cat. No.	Product Name	Target	Research Area	Image

HY-P990603

IMC-C103C RG-6290	Inhibitory Antibodies	Inflammation/Immunology
IMC-C103C is a human antibody expressed in CHO cells, targeting *MAGE-A4*. IMC-C103C contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for IMC-C103C can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Species:	Human (5)
Tag:	His (5) Avi (4)
Source:	HEK293 (5)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P77750

	*HLA-A02:01&B2M&MAGE-A4(GVYDGREHTV) Monomer Protein, Human (HEK293, His-Avi)** HLA0201; MHC I; MAGE-A4; CT1.4; MAGE4A; MAGE4B; MAGE-X2; member 4	Human	HEK293

HY-P77752

	*HLA-A02:01&B2M&MAGE-A4(GVYDGREHTV) Tetramer Protein, Human (HEK293, His-Avi)** HLA0201; MHC I; MAGE-A4; CT1.4; MAGE4A; MAGE4B; MAGE-X2; member 4	Human	HEK293

HY-P77751

	*HLA-A02:01&B2M&MAGE-A4(GVYDGREHTV) Monomer Protein, Human (Biotinylated, HEK293, His-Avi)** HLA0201; MHC I; MAGE-A4; CT1.4; MAGE4A; MAGE4B; MAGE-X2; member 4	Human	HEK293

HY-P705327

	*HLA-A02:01&B2M&MAGE-A4(KVLEHVVRV) Monomer Protein, Human (Biotinylated, HEK293, His-Avi)** HLA-A0201 & B2M & MAGE*-A4 (KVLEHVVRV)	Human	HEK293

HY-P700420

	MAGEA4 Protein, Human (HEK293, His) MAGEA4; melanoma antigen family A, 4; MAGE4; melanoma-associated antigen 4; cancer/testis antigen family 1; member 4; CT1.4; MAGE 41; MAGE X2; MAGE4A; MAGE4B; melanoma associated antigen 4; MGC21336	Human	HEK293
	MAGEA4 protein critically regulates cell proliferation by inhibiting G1 phase arrest and negatively modulates p53-mediated apoptosis. Its role in controlling key checkpoints emphasizes its impact on cellular homeostasis, suggesting significance in averting aberrant cell growth. MAGEA4 Protein, Human (HEK293, His) is the recombinant human-derived MAGEA4 protein, expressed by HEK293 , with C-10*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Mouse (4)
Reactivity:	Human (4) Rat (2) Mouse (2)
Application:	IHC-P (4) WB (4) FC (4) ELISA (2)
Isotype:	IgG1 (2) IgG2a (2)
Conjugation:	Non-conjugated (4) Biotin (2)
Clonality:	Monoclonal (2)
Modification:	Unmodified (2)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P84325

	MAGEA4 Antibody (YA4022) CT1.4; MAGE4; MAGE4A; MAGE4B; MAGE-41; MAGE-X2	WB, IHC-P, FC, ELISA	Human, Mouse, Rat
	MAGEA4 Antibody (YA4022) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MAGEA4.

HY-P88116

	MAGEA4 Antibody (YA7800) CT1.4; MAGE-41; MAGE-X2; MAGE4; MAGE4A; MAGE4B	WB, IHC-P, FC	Human
	MAGEA4 Antibody (YA7800) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to MAGEA4.

HY-P84325A

	MAGEA4 Antibody (YA4022)(PBS only) CT1.4; MAGE4; MAGE4A; MAGE4B; MAGE-41; MAGE-X2	WB, IHC-P, FC, ELISA	Human, Mouse, Rat
	MAGEA4 Antibody (YA4022) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MAGEA4.

HY-P88116A

	MAGEA4 Antibody (YA7800)(PBS only) CT1.4; MAGE-41; MAGE-X2; MAGE4; MAGE4A; MAGE4B	WB, IHC-P, FC	Human
	MAGEA4 Antibody (YA7800) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to MAGEA4.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-RS07969

MAGEA4 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
MAGEA4 Human Pre-designed siRNA Set A contains three designed siRNAs for MAGEA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS21150

Magea4 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Magea4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Magea4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS27666

Magea4 Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Magea4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Magea4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

MedchemExpress Validation 03

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred

MedchemExpress Validation 04

MedchemExpress Validation

We use cookies

MedChemExpress values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Privacy and Cookie Policy

Name
Email *

	Sorry, but the email address you supplied was invalid.